WHWK
Whitehawk Therapeutics Inc.

6,457
Mkt Cap
$97.56M
Volume
266,895.00
52W High
$3.81
52W Low
$1.39
PE Ratio
15.24
WHWK Fundamentals
Price
$2.07
Prev Close
$2.10
Open
$2.10
50D MA
$2.08
Beta
0.98
Avg. Volume
4.53M
EPS (Annual)
-$2.36
P/B
0.62
Rev/Employee
$649,575.00
Loading...
Loading...
Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
40

Frequently Asked Questions

What is Market Cap of Whitehawk Therapeutics Inc.?
What is the 52-week high for Whitehawk Therapeutics Inc.?
What is the 52-week low for Whitehawk Therapeutics Inc.?
What is Whitehawk Therapeutics Inc. stock price today?
What was Whitehawk Therapeutics Inc. stock price yesterday?
What is the PE ratio of Whitehawk Therapeutics Inc.?
What is the Price-to-Book ratio of Whitehawk Therapeutics Inc.?
What is the 50-day moving average of Whitehawk Therapeutics Inc.?
How many employess does Whitehawk Therapeutics Inc. has?

Latest WHWK News

View

Advertisement|Remove ads.

Advertisement|Remove ads.